Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Likes National Express, Stagecoach

Thu, 26th Mar 2015 09:41

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
PANMURE CUTS WHITBREAD TO 'SELL' ('HOLD') - TARGET 4250 PENCE
----------
S&P CAPITAL RAISES SEVERN TRENT TO SELL (STRONG SELL) - TARGET 1800(1700) PENCE
----------
GOLDMAN RAISES SEVERN TRENT PRICE TARGET TO 2222 (2207) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES AVIVA PRICE TARGET TO 650 (630) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES DIRECT LINE PRICE TARGET TO 350 (320) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1900 (1780) PENCE - 'BUY'
----------
JPMORGAN RAISES UNILEVER PLC PRICE TARGET TO 2750 (2400) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES RECKITT BENCKISER PRICE TARGET TO 5950 (5000) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES HIKMA PHARMACEUTICALS TARGET TO 2500 (2250) PENCE - 'OW'
----------
CREDIT SUISSE RAISES WOLSELEY PRICE TARGET TO 4400 (4000) PENCE - 'OUTPERFORM'
----------
DAVY CUTS WOLSELEY TO 'NEUTRAL' ('OUTPERFORM')
----------
TRADERS: INVESTEC CUTS ANTOFAGASTA TO 'SELL' ('HOLD')
----------
TRADERS: CREDIT SUISSE RAISES LEGAL & GENERAL PRICE TARGET TO 285 (275) PENCE
----------
DEUTSCHE BANK RAISES STANDARD LIFE PRICE TARGET TO 445 (416) PENCE - 'HOLD'
----------
TRADERS: CANACCORD RAISES STANDARD LIFE PRICE TARGET TO 465 (425) PENCE
----------
FTSE 250
----------
NUMIS RAISES TULLETT PREBON PRICE TARGET TO 420 (360) PENCE - 'ADD'
----------
NUMIS CUTS GENUS TO 'HOLD' ('ADD') - TARGET 1426 (1290) PENCE
----------
TRADERS: PANMURE CUTS AVEVA GROUP PRICE TARGET TO 1907 (1935) PENCE
----------
JPMORGAN RAISES INFORMA PRICE TARGET TO 670 (585) PENCE - 'OVERWEIGHT'
----------
Investec Places SuperGroup Price Target Under Review From 1,030p, Keeps At Buy
----------
TRADERS: INVESTEC RAISES GRAFTON GROUP PRICE TARGET TO 860 (730) PENCE
----------
BARCLAYS INITIATES GO-AHEAD GROUP WITH 'EQUAL WEIGHT' - TARGET 2744 PENCE
----------
BARCLAYS INITIATES FIRSTGROUP WITH 'EQUAL WEIGHT' - TARGET 110 PENCE
----------
BARCLAYS INITIATES STAGECOACH WITH 'OVERWEIGHT' - TARGET 412 PENCE
----------
BARCLAYS INITIATES NATIONAL EXPRESS WITH 'OVERWEIGHT' - TARGET 331 PENCE
----------
GOLDMAN RAISES BETFAIR PRICE TARGET TO 2665 (1935) PENCE - 'BUY'
----------
GOLDMAN RAISES BELLWAY PRICE TARGET TO 2595 (2590) PENCE - 'BUY'
----------
GOLDMAN RAISES POLYMETAL TO 'CONVICTION BUY LIST' ('BUY') - TARGET 690 (670) PENCE
----------
TRADERS: GOLDMAN CUTS BOOKER GROUP TO 'NEUTRAL' ('BUY')
----------
DEUTSCHE BANK RAISES ESURE GROUP PRICE TARGET TO 260 (255) PENCE - 'HOLD'
----------
TRADERS: JEFFERIES RAISES OPHIR ENERGY TO 'BUY' ('HOLD')
----------
TRADERS: CREDIT SUISSE CUTS SERCO PRICE TARGET TO 171 (208) PENCE
----------
UBS RAISES SAVILLS PRICE TARGET TO 900 (820) PENCE - 'BUY'
----------
UBS RAISES GREGGS PRICE TARGET TO 1120 (960) PENCE - 'BUY'
----------
N+1 Singer Downgrades Euromoney To Hold From Buy, Keeps Price Target At 1,100p
----------
MAIN MARKET AND AIM
----------
Jefferies Upgrades Breedon Aggregates To Buy From Hold
----------
NUMIS CUTS POLYPIPE TO 'ADD' ('BUY') - TARGET 300 PENCE
----------
NUMIS CUTS ONESAVINGS BANK TO 'HOLD' ('ADD') - TARGET 252 PENCE
----------
NUMIS CUTS BOOT TO 'ADD' ('BUY') - TARGET 265 (254) PENCE
----------
LIBERUM RAISES BELLWAY PRICE TARGET TO 2352 (2278) PENCE - 'BUY'
----------
TRADERS: DEUTSCHE BANK RAISES BELLWAY PRICE TARGET TO 2104 (1793) PENCE
----------
PANMURE CUTS HILL & SMITH TO 'HOLD' ('BUY') - TARGET 716 PENCE
----------
DEUTSCHE BANK RAISES PARTNERSHIP ASSURANCE TARGET TO 130 (120) PENCE - 'HOLD'
----------
TRADERS: HSBC RAISES STHREE PRICE TARGET TO 400 (312) PENCE
----------
TRADERS: JEFFERIES RAISES MARSHALLS GROUP TO 'BUY' ('HOLD')
----------
UBS RAISES PREMIER FARNELL PRICE TARGET TO 190 (165) PENCE - 'NEUTRAL'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.